JPRN-UMIN000039174已完成未知
Clinical significance of serum PR3-ANCA in ulcerative colitis - Clinical significance of serum PR3-ANCA in ulcerative colitis
Department of Gastroenterology, Kagawa Prefectural Central Hospital0 个研究点目标入组 158 人开始时间: 2020年1月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 158
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 5years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Cases excluded were patients ages 0 to 5 or with a complication that could be serum positive for PR3-ANCA or MPO-ANCA such as autoimmune disease, chronic extraintestinal inflammatory disease, malignant tumor, or hyperthyroidism, and patients being treated or with a history of treatment with TNF alpha inhibitors, (infliximab and adalimumab), which have the potential to cause drug-induced ANCA-associated vasculitis. Also excluded from analysis were patients being treated or with a history of treatment with steroids or immunoregulators and serum PR3-ANCA levels below the detection limit.
研究者
相似试验
已完成
不适用
The Clinical Significance of Plasma Pentraxin 3 levels for Patients with Diastolic Heart FailurePatients with heart failureJPRN-UMIN000002170Graduate School of Medical Sciences, Kumamoto University200
尚未招募
不适用
Predictive factor analysis for treatment of Ulcerative Colitis with TofacitinibJPRN-UMIN000035011agasaki University Hospital15
进行中（未招募）
不适用
Chemopreventive effects of 5-ASA and UDCA in Ulcerative Colitis:A Double-blind, Randomized Placebo-controlled Pilot Study - CRC chemoprevention in UClcerative Colitis and the risk of developing colorectal cancer.MedDRA version: 13.1Level: PTClassification code 10021972Term: Inflammatory bowel diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2009-010921-38-NLMC Utrecht
已完成
2 期
Chemopreventive effects of 5-ASA and UDCA in Ulcerative Colitis: A Double-blind, Randomized Placebo-controlled Pilot StudyInflammatory bowel disease1001796910017991Ulcerative ColitisNL-OMON36920niversitair Medisch Centrum Utrecht45
撤回
2 期
Chemopreventive effects of 5-ASA and UDCA in Ulcerative Colitis: A Double-blind, Randomized Placebo-controlled Pilot Studyulcerative colitisNL-OMON31889niversitair Medisch Centrum Utrecht45